Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      Reports on a random trial to compare irinotecan, a topoisomerase I inhibitor, with supportive care alone for survival, quality of life, and other clinical variables in patients with metastatic colorectal cancer, and for whom fluorouracil has failed. Methods; Findings; Interpretation.